Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BASILEA PHARMACEUTICA AG

(BSLN)
  Report
Delayed Swiss Exchange  -  11:30 2022-12-02 am EST
49.35 CHF   -0.80%
11/24Basilea Pharmaceutica : Updated November 24, 2022
PU
11/02Basilea To Sell Preclinical CLK Kinase Inhibitors To Twentyeight-Seven Therapeutics
MT
11/02Basilea announces sale of preclinical oncology program to Twentyeight-Seven Therapeutics
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
ETFs positioned on BASILEA PHARMACEUTICA AGETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
UBS ETF (CH) MSCI Switzerland IMI Socially ...0.11%-0.02%-NC
UBS ETF - MSCI Switzerland IMI Socially Res...0.11%0.12%-NC
UBS ETF (CH) - MSCI Switzerland IMI Sociall...0.08%0.11%-NC
IShares MSCI Europe Small-Cap ETF - USD0.05%1.46%Europe
Vanguard FTSE All-World ex-US Small-Cap ETF - USD0.05%2.08%World
UBS ETF (CH) - SPI ESG A-acc - CHF0.03%0.61%-NC
IShares MSCI EAFE Small-Cap ETF - USD0.02%1.28%EAFE
Vanguard MSCI International Small Companies...0.01%0.07%-World
Vanguard FTSE Developed Europe All Cap Inde...0%2.48%Europe



Copyright ę 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ôInformationö) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Chart BASILEA PHARMACEUTICA AG
Duration : Period :
Basilea Pharmaceutica AG Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 49,35 CHF
Average target price 68,58 CHF
Spread / Average Target 39,0%
Chart BASILEA PHARMACEUTICA AG
Duration : Period :
Basilea Pharmaceutica AG Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
BASILEA PHARMACEUTICA AG20.60%624
MODERNA, INC.-28.20%70 055
IQVIA HOLDINGS INC.-22.83%40 441
LONZA GROUP AG-33.82%39 802
ALNYLAM PHARMACEUTICALS, INC.38.22%28 838
SEAGEN INC.-20.82%22 727